These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 4608970
1. [Therapeutic trial of a normolipemic agent: ethanolamine N-oxy-nicotinate]. Warembourg H, Ketelers JY, Ginestet A. Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1331-5. PubMed ID: 4608970 [No Abstract] [Full Text] [Related]
2. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)]. Proto C, Quadri A, Ratti S, Levi GF, Prandini BD. G Ital Cardiol; 1978 Dec; 8(7):743-51. PubMed ID: 355033 [Abstract] [Full Text] [Related]
3. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)]. Levy H. Med Klin; 1974 Sep 06; 69(36):1441-7. PubMed ID: 4280008 [No Abstract] [Full Text] [Related]
4. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)]. Fourrier A, Mouton Y. Lille Med; 1974 Apr 06; 19(4 Suppl 11):532-7. PubMed ID: 4612283 [No Abstract] [Full Text] [Related]
7. [The management of hyperlipoproteinemia with Liproreduct]. Fenster R. Ther Ggw; 1974 May 06; 113(5):813-24. PubMed ID: 4603893 [No Abstract] [Full Text] [Related]
8. [Clinical experimentation of clofibride. Apropos of 40 cases]. Warembourg H, Jaillard J. Lille Med; 1973 Dec 06; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928 [No Abstract] [Full Text] [Related]
9. A long-term trial of gemfibrozil in the treatment of hyperlipidaemias. Eisalo A, Manninen V. Proc R Soc Med; 1976 Dec 06; 69 Suppl 2(Suppl 2):49-52. PubMed ID: 798198 [No Abstract] [Full Text] [Related]
10. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial. Eisalo A, Manninen V. Proc R Soc Med; 1976 Dec 06; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196 [No Abstract] [Full Text] [Related]
11. [Hypolipemic effects of 1-10(hydroxy-2 ethylthio) decane (LL1558), based on 77 cases of essential hyperlipidemia]. Rouffy J, Loeper J. Therapie; 1972 Dec 06; 27(3):433-44. PubMed ID: 4570211 [No Abstract] [Full Text] [Related]
12. [Therapeutic orientation in the hyperlipidemias]. Forti N, Diament J, Giannini SD. Arq Bras Cardiol; 1979 Sep 06; 33(3):207-15. PubMed ID: 396911 [No Abstract] [Full Text] [Related]
15. [New drug combination for medical management of hyperlipemia: clinical study]. Fischer M, Falkensammer C. Int J Clin Pharmacol Biopharm; 1977 Dec 06; 15(12):585-9. PubMed ID: 340391 [Abstract] [Full Text] [Related]
16. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative. Oriente P, Motolese M, Cerqua R, Mancini M. Int Z Klin Pharmakol Ther Toxikol; 1969 Oct 06; 2(4):348-53. PubMed ID: 4903988 [No Abstract] [Full Text] [Related]
17. [Antilipemic drugs]. Schwandt P. Med Monatsschr Pharm; 1980 Oct 06; 3(10):302-5. PubMed ID: 7007844 [No Abstract] [Full Text] [Related]
19. CI-719 in hyperlipoproteinaemia: interim data. Bremner WF, Third JL, Clark B, Corstorphine C, Lawrie TD. Proc R Soc Med; 1976 Oct 06; 69 Suppl 2(Suppl 2):83-7. PubMed ID: 798201 [No Abstract] [Full Text] [Related]
20. [Controversies and advances in the treatment of hyperlipidemias]. Reza-Albarrán A, Aguilar-Salinas CA. Gac Med Mex; 1998 Oct 06; 134(2):253-6. PubMed ID: 9619005 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]